100 related articles for article (PubMed ID: 7834612)
1. Pharmacokinetics of 9-cis-retinoic acid in the rhesus monkey.
Adamson PC; Murphy RF; Godwin KA; Ulm EH; Balis FM
Cancer Res; 1995 Feb; 55(3):482-5. PubMed ID: 7834612
[TBL] [Abstract][Full Text] [Related]
2. Time course of induction of metabolism of all-trans-retinoic acid and the up-regulation of cellular retinoic acid-binding protein.
Adamson PC; Boylan JF; Balis FM; Murphy RF; Godwin KA; Gudas LJ; Poplack DG
Cancer Res; 1993 Feb; 53(3):472-6. PubMed ID: 8381046
[TBL] [Abstract][Full Text] [Related]
3. Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid.
Tzimas G; Nau H; Hendrickx AG; Peterson PE; Hummler H
Teratology; 1996 Nov; 54(5):255-65. PubMed ID: 9035347
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of 13-cis-, all-trans-, 13-cis-4-oxo-, and all-trans-4-oxo retinoic acid after intravenous administration in the cynomolgus monkey.
Sandberg JA; Eckhoff C; Nau H; Slikker W
Drug Metab Dispos; 1994; 22(1):154-60. PubMed ID: 8149876
[TBL] [Abstract][Full Text] [Related]
5. Plasma pharmacokinetics and metabolism of 13-cis- and all-trans-retinoic acid in the cynomolgus monkey and the identification of 13-cis- and all-trans-retinoyl-beta-glucuronides. A comparison to one human case study with isotretinoin.
Kraft JC; Slikker W; Bailey JR; Roberts LG; Fischer B; Wittfoht W; Nau H
Drug Metab Dispos; 1991; 19(2):317-24. PubMed ID: 1676630
[TBL] [Abstract][Full Text] [Related]
6. Maternal toxicokinetics, metabolism, and embryo exposure following a teratogenic dosing regimen with 13-cis-retinoic acid (isotretinoin) in the cynomolgus monkey.
Hummler H; Hendrickx AG; Nau H
Teratology; 1994 Sep; 50(3):184-93. PubMed ID: 7871482
[TBL] [Abstract][Full Text] [Related]
7. Comparative teratology and transplacental pharmacokinetics of all-trans-retinoic acid, 13-cis-retinoic acid, and retinyl palmitate following daily administrations in rats.
Collins MD; Tzimas G; Hummler H; Bürgin H; Nau H
Toxicol Appl Pharmacol; 1994 Jul; 127(1):132-44. PubMed ID: 8048045
[TBL] [Abstract][Full Text] [Related]
8. Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid.
Nau H
J Am Acad Dermatol; 2001 Nov; 45(5):S183-7. PubMed ID: 11606951
[TBL] [Abstract][Full Text] [Related]
9. Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice.
Achkar CC; Bentel JM; Boylan JF; Scher HI; Gudas LJ; Miller WH
Drug Metab Dispos; 1994; 22(3):451-8. PubMed ID: 8070324
[TBL] [Abstract][Full Text] [Related]
10. Identification of 9,13-dicis-retinoic acid as a major plasma metabolite of 9-cis-retinoic acid and limited transfer of 9-cis-retinoic acid and 9,13-dicis-retinoic acid to the mouse and rat embryos.
Tzimas G; Sass JO; Wittfoht W; Elmazar MM; Ehlers K; Nau H
Drug Metab Dispos; 1994; 22(6):928-36. PubMed ID: 7895612
[TBL] [Abstract][Full Text] [Related]
11. Steady state pharmacokinetics of oral treatment with 13-cis-retinoic acid or all-trans-retinoic acid in male and female adult rats.
Ferguson SA; Siitonen PH; Cisneros FJ; Gough B; Young JF
Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):582-7. PubMed ID: 16700821
[TBL] [Abstract][Full Text] [Related]
12. All-trans-retinoic acid in maternal plasma and teratogenicity in rats and rabbits.
Tembe EA; Honeywell R; Buss NE; Renwick AG
Toxicol Appl Pharmacol; 1996 Dec; 141(2):456-72. PubMed ID: 8975771
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of all-trans retinoic acid, 13-cis retinoic acid, and fenretinide in plasma and brain of Rat.
Le Doze F; Debruyne D; Albessard F; Barre L; Defer GL
Drug Metab Dispos; 2000 Feb; 28(2):205-8. PubMed ID: 10640519
[TBL] [Abstract][Full Text] [Related]
14. Single versus multiple dose administration of all-trans-retinoic acid during organogenesis: differential metabolism and transplacental kinetics in rat and rabbit.
Collins MD; Tzimas G; Bürgin H; Hummler H; Nau H
Toxicol Appl Pharmacol; 1995 Jan; 130(1):9-18. PubMed ID: 7839374
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of 13-cis-retinoic acid in patients with advanced cancer.
Goodman GE; Einspahr JG; Alberts DS; Davis TP; Leigh SA; Chen HS; Meyskens FL
Cancer Res; 1982 May; 42(5):2087-91. PubMed ID: 7039822
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancer.
Adamson PC
Leukemia; 1994 Nov; 8(11):1813-6. PubMed ID: 7967727
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent pharmacokinetics of all-trans-retinoic acid.
Adamson PC; Balis FM; Smith MA; Murphy RF; Godwin KA; Poplack DG
J Natl Cancer Inst; 1992 Sep; 84(17):1332-5. PubMed ID: 1495103
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of oral all-trans retinoic acid in patients with acute promyelocytic leukemia.
Lefebvre P; Thomas G; Gourmel B; Agadir A; Castaigne S; Dreux C; Degos L; Chomienne C
Leukemia; 1991 Dec; 5(12):1054-8. PubMed ID: 1774953
[TBL] [Abstract][Full Text] [Related]
19. Teratogenicity and transplacental pharmacokinetics of 13-cis-retinoic acid in rabbits.
Eckhoff C; Chari S; Kromka M; Staudner H; Juhasz L; Rudiger H; Agnish N
Toxicol Appl Pharmacol; 1994 Mar; 125(1):34-41. PubMed ID: 8128493
[TBL] [Abstract][Full Text] [Related]
20. Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancer.
Adamson PC
Leukemia; 1994; 8 Suppl 3():S22-5. PubMed ID: 7808020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]